Webinar Q and A follow-up: ‘Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial’
Follow-up of the live webinar Q and A session
Please sign in or register for FREE
Sign in to RegMedNet
Or sign in via
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.